Taken together, the AMPK-SIRT1/ROS-MAPK/CLOCK-BMAL1 regulatory axis may become a new target for the prevention and treatment of atherosclerosis in the future, pending validation by other investigators. The gene discussed is PRKAA1; the disease is atherosclerosis.